Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 6
1992 1
1993 1
1994 3
1997 1
1998 1
2000 2
2001 2
2002 1
2003 1
2004 3
2005 6
2006 3
2007 3
2008 4
2009 19
2010 15
2011 10
2012 16
2013 30
2014 17
2015 19
2016 19
2017 22
2018 21
2019 25
2020 19
2021 20
2022 18
2023 25
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer.
Shitara K, Bang YJ, Iwasa S, Sugimoto N, Ryu MH, Sakai D, Chung HC, Kawakami H, Yabusaki H, Lee J, Saito K, Kawaguchi Y, Kamio T, Kojima A, Sugihara M, Yamaguchi K; DESTINY-Gastric01 Investigators. Shitara K, et al. N Engl J Med. 2020 Jun 18;382(25):2419-2430. doi: 10.1056/NEJMoa2004413. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469182 Clinical Trial.
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
Powles T, Valderrama BP, Gupta S, Bedke J, Kikuchi E, Hoffman-Censits J, Iyer G, Vulsteke C, Park SH, Shin SJ, Castellano D, Fornarini G, Li JR, Gümüş M, Mar N, Loriot Y, Fléchon A, Duran I, Drakaki A, Narayanan S, Yu X, Gorla S, Homet Moreno B, van der Heijden MS; EV-302 Trial Investigators. Powles T, et al. N Engl J Med. 2024 Mar 7;390(10):875-888. doi: 10.1056/NEJMoa2312117. N Engl J Med. 2024. PMID: 38446675 Clinical Trial.
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Rini BI, Plimack ER, Stus V, Gafanov R, Hawkins R, Nosov D, Pouliot F, Alekseev B, Soulières D, Melichar B, Vynnychenko I, Kryzhanivska A, Bondarenko I, Azevedo SJ, Borchiellini D, Szczylik C, Markus M, McDermott RS, Bedke J, Tartas S, Chang YH, Tamada S, Shou Q, Perini RF, Chen M, Atkins MB, Powles T; KEYNOTE-426 Investigators. Rini BI, et al. N Engl J Med. 2019 Mar 21;380(12):1116-1127. doi: 10.1056/NEJMoa1816714. Epub 2019 Feb 16. N Engl J Med. 2019. PMID: 30779529 Clinical Trial.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Powles T, Csőszi T, Özgüroğlu M, Matsubara N, Géczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, Fléchon A, Gunduz S, Loriot Y, Rodriguez-Vida A, Mamtani R, Yu EY, Nam K, Imai K, Homet Moreno B, Alva A; KEYNOTE-361 Investigators. Powles T, et al. Lancet Oncol. 2021 Jul;22(7):931-945. doi: 10.1016/S1470-2045(21)00152-2. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051178 Clinical Trial.
Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach.
Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW, Kim BJ, Min BH, Choi CI, Shin CM, Tae CH, Gong CS, Kim DJ, Cho AE, Gong EJ, Song GJ, Im HS, Ahn HS, Lim H, Kim HD, Kim JJ, Yu JI, Lee JW, Park JY, Kim JH, Song KD, Jung M, Jung MR, Son SY, Park SH, Kim SJ, Lee SH, Kim TY, Bae WK, Koom WS, Jee Y, Kim YM, Kwak Y, Park YS, Han HS, Nam SY, Kong SH; Development Working Groups for the Korean Practice Guidelines for Gastric Cancer 2022 Task Force Team. Kim TH, et al. Among authors: bae wk. J Gastric Cancer. 2023 Jan;23(1):3-106. doi: 10.5230/jgc.2023.23.e11. J Gastric Cancer. 2023. PMID: 36750993 Free PMC article. Review.
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction Cancer.
Kim CG, Jung M, Kim HS, Lee CK, Jeung HC, Koo DH, Bae WK, Zang DY, Kim BJ, Kim H, Yun UJ, Che J, Park S, Kim TS, Kwon WS, Park J, Cho SW, Nam CM, Chung HC, Rha SY. Kim CG, et al. Among authors: bae wk. J Clin Oncol. 2023 Sep 20;41(27):4394-4405. doi: 10.1200/JCO.22.02122. Epub 2023 Jun 26. J Clin Oncol. 2023. PMID: 37364218
Full-blown hyperparathyroidism.
Bae WK, Chung IJ. Bae WK, et al. Korean J Intern Med. 2018 Nov;33(6):1258-1259. doi: 10.3904/kjim.2012.092. Epub 2017 Nov 24. Korean J Intern Med. 2018. PMID: 29166761 Free PMC article. No abstract available.
Interface polarization in heterovalent core-shell nanocrystals.
Jeong BG, Chang JH, Hahm D, Rhee S, Park M, Lee S, Kim Y, Shin D, Park JW, Lee C, Lee DC, Park K, Hwang E, Bae WK. Jeong BG, et al. Among authors: bae wk. Nat Mater. 2022 Feb;21(2):246-252. doi: 10.1038/s41563-021-01119-8. Epub 2021 Nov 18. Nat Mater. 2022. PMID: 34795403
Nondestructive Photopatterning of Heavy-Metal-Free Quantum Dots.
Yang J, Lee M, Park SY, Park M, Kim J, Sitapure N, Hahm D, Rhee S, Lee D, Jo H, Jo YH, Lim J, Kim J, Shin TJ, Lee DC, Kwak K, Kwon JS, Kim B, Bae WK, Kang MS. Yang J, et al. Among authors: bae wk. Adv Mater. 2022 Oct;34(43):e2205504. doi: 10.1002/adma.202205504. Epub 2022 Sep 22. Adv Mater. 2022. PMID: 35985813
A Bioinspired Stretchable Sensory-Neuromorphic System.
Kim SH, Baek GW, Yoon J, Seo S, Park J, Hahm D, Chang JH, Seong D, Seo H, Oh S, Kim K, Jung H, Oh Y, Baac HW, Alimkhanuly B, Bae WK, Lee S, Lee M, Kwak J, Park JH, Son D. Kim SH, et al. Among authors: bae wk. Adv Mater. 2021 Nov;33(44):e2104690. doi: 10.1002/adma.202104690. Epub 2021 Sep 12. Adv Mater. 2021. PMID: 34510591
306 results